Your account is not claimed yet. You can sign up with ORCID to claim your account.

Patricia Sarlos (Patrícia Sarlós)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

BMJ open

Therapeutic advances in gastroenterology

Children (Basel, Switzerland)

Nutrients

University of Pecs

University of Pecs (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pecs

Hungary

senior lecturere :: 1st Department of Internal Medicine, Division of Gastroenterology

Education History

University of Pecs

Hungary

PHD

Publications

Dóra Dohos, Alex Váradi, Nelli Farkas, Adrienn Erős, Katalin Eszter Müller, Anna Karoliny, Eszter Gombos, Éva Nemes, Noémi Vass, Andras Tarnok, Péter Hegyi, Patricia Sarlos
Hungarian Linguistic, Cross-Cultural and Age Adaptation of Transition Specific Questionnaires in Patients with Inflammatory Bowel Disease. Children (Basel, Switzerland) 10 (4) (2023)
Patricia Sarlos, Alexander Bikar, Nelli Farkas, Tamás Resál, Zoltán Szepes, Klaudia Farkas, Ferenc Nagy, Áron Vincze, Pal Miheller, Tamás Molnár
Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease: results of a multicenter survey. Expert opinion on biological therapy (2023)
Dóra Dohos, Alex Váradi, Nelli Farkas, Adrienn Erős, Katalin Eszter Müller, Anna Karoliny, Eszter Gombos, Éva Nemes, Noémi Vass, Andras Tarnok, Péter Hegyi, Patricia Sarlos
Hungarian Linguistic, Cross-Cultural and Age Adaptation of Transition Specific Questionnaires in Patients with Inflammatory Bowel Disease. Children (Basel, Switzerland) 10 (4) (2023)
Péter Bacsur, Mária Matuz, Tamás Resál, Pál Miheller, Tamás Szamosi, Eszter Schäfer, Patricia Sarlos, Ákos Iliás, Kata Judit Szántó, Mariann Rutka, Anita Bálint, Ágnes Csontos, Anna Fábián, Renáta Bor, Zoltán Szepes, Tamás Molnár, Klaudia Farkas
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study. Therapeutic advances in gastroenterology 15 (2022)
Rita Nagy, Klementina Ocskay, Alex Váradi, Mária Papp, Zsuzsanna Vitális, Ferenc Izbéki, Eszter Boros, László Gajdán, Andrea Szentesi, Bálint Erőss, Péter Jenő Hegyi, Áron Vincze, Judit Bajor, Patricia Sarlos, Alexandra Mikó, Katalin Márta, Dániel Pécsi, Andrea Párniczky, Péter Hegyi
In-Hospital Patient Education Markedly Reduces Alcohol Consumption after Alcohol-Induced Acute Pancreatitis. Nutrients 14 (10) (2022)
Péter Bacsur, Mária Matuz, Tamás Resál, Pál Miheller, Tamás Szamosi, Eszter Schäfer, Patricia Sarlos, Ákos Iliás, Kata Judit Szántó, Mariann Rutka, Anita Bálint, Ágnes Csontos, Anna Fábián, Renáta Bor, Zoltán Szepes, Tamás Molnár, Klaudia Farkas
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study. Therapeutic advances in gastroenterology 15 (2022)
Szabolcs Kiss, Dávid Németh, Bálint Erőss, Mária Földi, Péter Hegyi, Bálint Erőss, Benedek Tinusz, Péter Jenő Hegyi, Patricia Sarlos, Hussain Alizadeh
Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta-analysis. BMJ open 11 (5) (2021)
Dóra Dohos, Lilla Hanák, Péter Hegyi, Szabolcs Kiss, Andrea Párniczky, Bálint Erőss, Piroska Pázmány, Bálint Erőss, Patricia Sarlos
Systematic review with meta-analysis: the effects of immunomodulator or biological withdrawal from mono- or combination therapy in inflammatory bowel disease. Alimentary pharmacology & therapeutics 53 (2) (2020)
Adrienn Erős, Dóra Dohos, Gábor Veres, András Tárnok, Áron Vincze, Alexandra Tészás, Noémi Zádori, Noémi Gede, Péter Hegyi, Patricia Sarlos
Effect of joint transition visits on quality of life in adolescents with inflammatory bowel diseases: a protocol for a prospective, randomised, multicentre, controlled trial (TRANS-IBD). BMJ open 10 (10) (2020)

Patricia Sarlos.css-eqlu8i{font-size:small;padding-left:4px;} (Patrícia Sarlós)

Publication Activity (10 Years)

Top Topics

Top Venues

Patricia Sarlos (Patrícia Sarlós)